Pharmacologic inhibition of platelet vWF-GPIb alpha interaction prevents coronary artery thrombosis

Thrombosis and Haemostasis
James K HennanGeorge P Vlasuk

Abstract

Under high shear arterial blood flow von Willebrand Factor (vWF) binds the platelet receptor glycoprotein (GP) Ibalpha, leading to platelet adhesion, activation and thrombosis. Blockade of vWF-GPIb alpha interactions by GPG-290 was investigated in a canine model of coronary artery thrombosis alone and in combination with clopidogrel. GPG-290 (100 microg/kg, n=6; 500 microg/kg, n=6) prolonged time to thrombotic occlusion (TTO) to 105+/-34 and 156+/-23 (p<0.05) min, respectively compared to the saline treated control group (32+/-6 min, n=6). Patency of the injured vessel was sustained in 1/6 (100 microg/kg) and 3/6 vessels (500 microg/kg) 4 hours after injury, in contrast to 0/6 in the control group. There was an increase in bleeding after the 500 microg/kg dose, but only at the 1 hr time point. Clopidogrel was studied in two dosing regimens representing either a clinical pretreatment regimen (PTR) of 4.3 mg/kg on day -2 followed by 1.1 mg/kg daily for 2 days prior to the procedure or pre-procedural loading dose regimen (LDR) of 4.3 mg/kg 3 hr pre-procedure. The PTR and LDR clopidogrel treatments prolonged TTO to 98.2+/-30.0 min and 136.1+/-39.5 min (p<0.05), and sustained patency in 1/6 and 4/8 vessels, respectively. However, te...Continue Reading

Citations

Aug 15, 2008·Cancer Research·Benoit Ho-Tin-NoéDenisa D Wagner
Mar 13, 2016·Journal of Veterinary Pharmacology and Therapeutics·J ThomasonA Mackin
Jan 12, 2013·Journal of Cardiovascular Translational Research·Jozef BartunekJosefin-Beate Holz
Nov 27, 2010·Expert Review of Cardiovascular Therapy·Christa FirbasBernd Jilma
Jun 16, 2012·Expert Review of Clinical Pharmacology·Kallirroi I KalantziAlexandros D Tselepis
Jan 18, 2019·Journal of Veterinary Emergency and Critical Care·Robert GoggsRonald H L Li
Sep 26, 2019·Current Pharmaceutical Design·Vivek K YadavSunil K Singh
Sep 18, 2007·Expert Review of Cardiovascular Therapy·Gregory DucrocqJean-Francois Tanguay
Mar 19, 2013·Future Medicinal Chemistry·Jens Minnerup, Christoph Kleinschnitz
Dec 20, 2011·Stroke; a Journal of Cerebral Circulation·Simon F De MeyerChristoph Kleinschnitz
Jan 18, 2019·Journal of Veterinary Emergency and Critical Care·Marie-Claude BlaisClaire R Sharp
Aug 2, 2018·Cancers·Annalisa BrunoPaola Patrignani
May 12, 2009·Journal of Thrombosis and Haemostasis : JTH·M Laffan, T A J McKinnon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.